InvestorsHub Logo
Followers 618
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: loanranger post# 265436

Saturday, 06/08/2019 6:45:39 PM

Saturday, June 08, 2019 6:45:39 PM

Post# of 402582
Based on the studies I've looked at I'd definitely ask the question if I were still doing management interviews. But, not being privy to all of the same information they are dealing with I won't hazard a guess at which route would be better using Brilacidin. There appear to be pros and cons and, I'm a bit curious as to what makes/made the final decision.

A Thermo-sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509789/

Colon Targeted Drug Delivery Systems: A Review on Primary and Novel Approaches
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215502/

Comparative study of enema retention and preference in ulcerative colitis
https://pmj.bmj.com/content/81/959/594






In Reply to the following portion of 'loanranger' post

If quicker is what you're looking for why not run the trial with the existing product?
I'm pretty sure you would ask that question if you were still doing management interviews.







To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News